The Use of Tissue Oxygen Monitoring in Critically Injured Patients
Sponsor: Centers for Disease Control and Prevention
Terminated
Slow to enroll.
Other terminated trials from Centers for Disease Control and Prevention
- Human Immunodeficiency Virus · Phase NA · May 2024
- Antibiotic Resistant Infection · Phase PHASE3 · Dec 2023
- Meningoencephalitis · Dec 2021
- Infection · Phase NA · Nov 2021
- Developmental Disability · Phase NA · Sep 2021
See all terminations from Centers for Disease Control and Prevention
This observational or N/A phase trial investigates Hemorrhagic Shock and Trauma and is currently terminated or withdrawn. Centers for Disease Control and Prevention leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .